Adcock Richard 4
4 · ImmunityBio, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Adcock Richard
DirectorCEO & President
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-31−34,483→ 86,214 total→ Common Stock (34,483 underlying) - Exercise/Conversion
Common Stock
2024-12-31+34,483→ 277,621 total - Tax Payment
Common Stock
2024-12-31$2.56/sh−17,475$44,736→ 260,146 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026.